Sugawara Y, Yamamoto J, Yamasaki S, Shimada K, Kosuge T, Makuuchi M
Department of Hepatobiliary Pancreatic Surgery, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Surgery. 2001 Apr;129(4):408-13. doi: 10.1067/msy.2001.112001.
The effect of the time interval between colorectal and liver resection for metastatic lesions on the patient's survival remains controversial. Pretreatment classification for predicting the prognosis of this disease has not yet been reported.
Nine clinical factors revealed by preoperative examinations, intraoperative screening before liver resection, and resection margin were examined in 304 patients who underwent hepatic resections for metastatic colorectal carcinoma. The patients were divided according to the timing of hepatectomy and both tumor number and maximum diameter to devise a staging system.
Tumor number and maximum tumor size were significant prognostic factors in the metachronous hepatectomy group, and resection margin was significant in the synchronous group. The following staging system was proposed: stage I, n < or = 3 and diameter < 5 cm in the metachronous hepatectomy group (n = 86); stage II, n < or = 3 and diameter > or = 5 cm in the metachronous hepatectomy group (n = 46); and stage III, n > or = 4 and diameter > 5 cm in the metachronous group and the synchronous hepatectomy group (n = 144).
The current study revealed that the factors that influenced the patient's prognosis were different between the synchronous and metachronous groups. It may be useful to develop a staging system that considers this difference.
结直肠癌与肝转移灶切除之间的时间间隔对患者生存的影响仍存在争议。尚未有关于预测该疾病预后的术前分类报道。
对304例行肝转移结直肠癌切除术的患者,检查术前检查、肝切除术前术中筛查及切缘所揭示的9项临床因素。根据肝切除时间、肿瘤数量和最大直径对患者进行分组,以设计一个分期系统。
在异时性肝切除组中,肿瘤数量和最大肿瘤大小是显著的预后因素,在同时性组中切缘是显著的预后因素。提出了以下分期系统:I期,异时性肝切除组中n≤3且直径<5 cm(n = 86);II期,异时性肝切除组中n≤3且直径≥5 cm(n = 46);III期,异时性组和同时性肝切除组中n≥4且直径>5 cm(n = 144)。
当前研究表明,同时性组和异时性组影响患者预后的因素不同。制定考虑这种差异的分期系统可能会有用。